PRTN3 and rheumatoid arthritis: There were significant differences between two groups (RA patients with ocular involvement vs RA patients without ocular involvement) in terms of sex, CRP, ACPA, IgG, IgA, IgM, and treatment with HCQ (Tables S2–S4).